• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Ready for takeoff: J&J's consumer health unit Kenvue files for official separation

cafead

Administrator
Staff member
  • cafead   Jan 05, 2023 at 05:12: PM
via J&J’s consumer health unit Kenvue filed for an IPO on Wednesday, setting in motion the long-anticipated plans for its official spinoff.

Kenvue is touting itself as the “world’s largest pure-play consumer health company,” with popular brands such as Neutrogena, Tylenol, Band-Aid and Listerine in tow. The unit raked in just over $15.1 billion in 2021.

article source